riTUXimab
Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RiTUXimab (Rituxan) | SOLUTION, INTRAVENOUS | 10 mg/mL (10 mL) | ||||||||||||||
RiTUXimab (Rituxan) | SOLUTION, INTRAVENOUS | 10 mg/mL (50 mL) | ||||||||||||||
RiTUXimab-abbs (Truxima) | SOLUTION, INTRAVENOUS | 10 mg/mL (10 mL) | ||||||||||||||
RiTUXimab-abbs (Truxima) | SOLUTION, INTRAVENOUS | 10 mg/mL (50 mL) | ||||||||||||||
RiTUXimab-pvvr (Ruxience) | SOLUTION, INTRAVENOUS | 10 mg/mL (10 mL) | ||||||||||||||
RiTUXimab-pvvr (Ruxience) | SOLUTION, INTRAVENOUS | 10 mg/mL (50 mL) |
UNC Health
System Formulary Restriction:
Use of Truxima injection for the treatment of rheumatoid arthritis is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Use of Ruxience injection is restricted to patients in outpatient or clinic encounters (ie, no inpatient use) who meet one of the following criteria:
Use of Rituxan injection is restricted to patients in outpatient or clinic encounters (ie, no inpatient use) who meet one of the following criteria:
Med Center
UNC Medical Center Formulary Restrictions
RiTUXimab for Treatment of Glomerular, Rheumatic or Auto-Immune Conditions, and Antibody Mediated Rejection Guideline
Pardee
RiTUXimab (Rituxan) Administration Procedure
Rex
Rex Hematology-Oncology Formulary Restrictions